Metsera, Inc.
MTSRNASDAQHealthcare
$70.50
$-0.25(-0.35%)
Market Cap$7.4B
P/E Ratio—
52W High$83.8599
52W Low$12.3
Metsera, Inc. (MTSR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MTSR · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 |
|---|---|---|
| Revenue | ||
| Revenue | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — |
| Operating Expenses | ||
| R&D Expenses | $0.11B | $0.02B |
| G&A Expenses | $0.03B | $0.02B |
| Total Operating Expenses | $0.22B | $0.04B |
| Operating Income | ($0.22B) | ($0.04B) |
| Operating Margin %(computed) | — | — |
| Interest Income | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B |
| Income Before Tax | ($0.22B) | ($0.05B) |
| Income Tax Expense | ($0.01B) | $0.00B |
| Net Income | ($0.21B) | ($0.05B) |
| Net Margin %(computed) | — | — |
| Per Share & EBITDA | ||
| EPS (Basic) | $-2.03 | $-0.95 |
| Wtd Avg Shares | 0.10B | 0.05B |
| EBITDA | ($0.22B) | ($0.05B) |
| EBITDA Margin %(computed) | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Metsera, Inc. data
About Metsera, Inc. (MTSR) Income Statement
Metsera, Inc. (MTSR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, MTSR reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.21B) — a net profit margin of —.
Frequently asked questions
MTSR · 4 questionsMetsera, Inc. (MTSR) reported revenue of $0.00B for 2024, down —% year-over-year.
MTSR revenueMTSR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08